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Abstract
Background: This study investigates differences in treatment and outcome of ventilated patients with acute
respiratory distress syndrome (ARDS) between university and non-university hospitals in Germany.
Methods: This subanalysis of a prospective, observational cohort study was performed to identify independent risk
factors for mortality by examining: baseline factors, ventilator settings (e.g., driving pressure), complications, and
care settings—for example, case volume of ventilated patients, size/type of intensive care unit (ICU), and type of
hospital (university/non-university hospital). To control for potentially confounding factors at ARDS onset and to
verify differences in mortality, ARDS patients in university vs non-university hospitals were compared using
additional multivariable analysis.
Results: Of the 7540 patients admitted to 95 ICUs from 18 university and 62 non-university hospitals in May 2004,
1028 received mechanical ventilation and 198 developed ARDS. Although the characteristics of ARDS patients were
very similar, hospital mortality was considerably lower in university compared with non-university hospitals (39.3%
vs 57.5%; p = 0.012). Treatment in non-university hospitals was independently associated with increased mortality
(OR (95% CI): 2.89 (1.31–6.38); p = 0.008). This was confirmed by additional independent comparisons between the
two patient groups when controlling for confounding factors at ARDS onset. Higher driving pressures (OR 1.10; 1
cmH2O increments) were also independently associated with higher mortality. Compared with non-university
hospitals, higher positive end-expiratory pressure (PEEP) (mean ± SD: 11.7 ± 4.7 vs 9.7 ± 3.7 cmH2O; p = 0.005) and
lower driving pressures (15.1 ± 4.4 vs 17.0 ± 5.0 cmH2O; p = 0.02) were applied during therapeutic ventilation in
university hospitals, and ventilation lasted twice as long (median (IQR): 16 (9–29) vs 8 (3–16) days; p < 0.001).
Conclusions: Mortality risk of ARDS patients was considerably higher in non-university compared with university
hospitals. Differences in ventilatory care between hospitals might explain this finding and may at least partially
imply regionalization of care and the export of ventilatory strategies to non-university hospitals.
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Background
Germany has the highest number of intensive care unit
(ICU) beds and admissions per capita, and this has been
related to the very low mortality due to sepsis compared
with other countries [1]. Nevertheless, with the exception
of one study performed in 1991 in Berlin [2] and studies
including selected acute respiratory distress syndrome
(ARDS) patients treated in referral centers [3–5], the
characteristics and outcome of unselected, ventilated
patients in Germany remain unknown.
The Second International Study of Mechanical Venti-
lation (Second VENTILA study) was carried out in 23
countries, and one in five of the included patients origi-
nated from Germany. However, because Germany did
not participate in the First VENTILA study, patients
from Germany were excluded from the comparative ana-
lyses [6, 7]. Therefore, in 2004 when a hospital mortality
of 63.2% was observed in patients with ARDS [7], pa-
tients from Germany had not been included. Mortality
in routine medical care, as reflected (at least partially) by
observational cohort studies [6–13], is usually higher
than in randomized trials [5, 14–20] in which, generally
speaking, less severely ill patients are enrolled. Random-
ized trials [5, 14–20] are mainly conducted in university
hospitals, as indeed are most observational studies
[9–13]; however, these university centers represent
only a very small proportion of all hospitals in which
ARDS patients are treated.
Many non-university hospitals participated in the Second
VENTILA study, in which the hospital mortality of ARDS
patients was 15.4% higher than that found in a Spanish
study conducted mainly in university hospitals (Acute Lung
Injury: Epidemiology and Natural History (ALIEN) study)
[7, 11]. Non-university hospitals also participated in the
King County Lung Injury Project (KCLIP study), in which
the low hospital mortality of 41.1% was partially related to
local healthcare settings with early discharge to other hospi-
tals, or to skilled nursing/rehabilitation facilities with acute
care beds [1, 21]. In this KCLIP study, mortality in the non-
university hospitals was 11.5% higher but patients were on
average 17 years older and had higher illness severity scores
compared with those in university hospitals [21]; whether
the setting independently affects the outcome of ARDS re-
mains unknown [9, 12, 22–24].
Many factors influence ARDS outcome [2–26] includ-
ing the underlying disease, appropriate treatment, and
the use of protective ventilation [15, 16, 24, 26]. Differ-
ent types of hospitals may implement lung protective
strategies to varying degrees. Also, taking into account
other variables that different hospitals may introduce
(e.g., case volume or staffing), we hypothesized that the
mortality risk for ARDS might be increased in non-
university hospitals compared with university hospitals,
irrespective of patient characteristics or other factors.
Therefore, this study aimed to determine whether differ-
ent types of care settings have an impact on the survival
of ARDS, and to assess differences in ventilatory care
that might be related to ARDS outcome.
Methods
As part of the Second VENTILA study [7], during a 1-
month period we enrolled adult patients who were ven-
tilated for at least 12 h invasively or 1 h non-invasively
after admission to an ICU in Germany. All participating
investigators and hospitals are listed in the Appendix.
This study was approved by the ethical committee of the
Medical School Hanover for all centers involved, and in-
formed consent was waived (No. 3575).
ARDS was defined according to the American–European
Consensus Conference; patients with acute lung injury
(ALI) who did not progress to ARDS were not included in
the analysis of the group diagnosed with ARDS [25]. On
ICU admission, severity of illness was evaluated with
the Simplified Acute Physiology Score II (SAPS II)
and organ dysfunctions were evaluated daily as de-
scribed by Esteban et al. [6–8].
ARDS patients treated in university hospitals were
compared with those treated in non-university hospitals.
The main outcome was overall hospital mortality: the
variables of ventilatory care, as well as the incidence and
incidence rates of complications, were analyzed to
explain potential differences in mortality. Therapeutic
ventilation was identified to exclude days of weaning by
selecting only those ventilator days with FiO2 > 0.4 and
PEEP > 5 cmH2O, which represented the minimum
values as criteria for the start of weaning in the low tidal
volume trial of the ARDS Network [16]. Depending on
the distribution of data, Student’s t test or the Mann–
Whitney U test was used to compare continuous data,
and the chi-square test or Fisher’s exact test to compare
proportions. The survival rate of ARDS patients was an-
alyzed using the Kaplan–Meier method and the log-rank
test was used to compare groups. p < 0.05 was consid-
ered statistically significant.
Multivariable analyses
As described in detail in Additional file 1, factors inde-
pendently associated with increased hospital mortality
were determined using explorative multivariable logistic
regression in which two multivariable models for pa-
tients with and without ARDS were employed. Briefly,
we first selected potential prognostic factors by means of
univariable analyses when variables were associated with
hospital mortality with p < 0.15 and, in addition, also by
entering predefined variables of potential clinical import-
ance following an expert-based selection process. Be-
cause entering too many predictors into a model and
collinearity between predictors can lead to unstable
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coefficient estimation, we then grouped these selected
variables into four variable categories:
(i) Patients’ baseline factors: age, sex, SAPS II, main
problem (medical/surgical), main reason for
initiation of ventilation (pneumonia, lung disease
other than pneumonia, sepsis, postoperative acute
respiratory failure (ARF), other ARF, neurological
reason), length of hospital stay prior to ventilation,
and (only in the ARDS group) origin of ARDS
(extrapulmonary/pulmonary).
(ii)Factors related to individual patient management:
driving pressure, tidal volume per kilogram of
predicted body weight, respiratory rate, plateau
pressure, PEEP, FiO2, PaO2/FiO2, pH, dynamic
compliance (mean of all ventilatory and gas
exchange variables from the first week after onset of
ARDS), successful non-invasive ventilation, high
plateau pressure (>30 cmH2O) on 2 consecutive
days, and use of sedatives or vasoactive drugs on 2
consecutive days.
(iii)Complications during ventilation: metabolic acidosis
(pH < 7.3 and PaCO2 < 45 mmHg), respiratory
acidosis (pH < 7.35 and PaCO2 > 55 mmHg),
pneumonia, barotrauma, hepatic failure, renal
failure, shock, coagulopathy, and lowest PaO2/FiO2
ratio.
(iv)Factors related to the setting of care: size of
hospital, size of the ICU, type of ICU (surgical/
medical, medical, surgical, neurological), case
volume of all patients admitted to the ICU, case
volume of mechanically ventilated patients as well as
case volume of mechanically ventilated patients per
bed, and university/non-university hospital.
In Germany, a university hospital is organized by a fed-
eral state and is directly affiliated to a medical faculty with
at least 150 new medical students per year and at least 60
professors teaching human medicine. Medical faculty and
university hospitals are institutionally linked and cooper-
ate within a joint governance structure. Research and
teaching is institutionally ensured by a legal mandate with
corresponding, independent funding. The hospital
provides the infrastructure for all or most of the medical
specialties that are necessary for teaching and research.
To select the variables for the final multivariable
models we then performed multivariable analyses within
each of these four variable categories separately for pa-
tients with and without ARDS. Only those variables con-
tributing with p < 0.10 to the multivariable analysis per
variable category were entered into the two overall final
models, thereby correcting for collinearity of predictors.
In the group of patients with ARDS, the variables that
contributed with p < 0.10 and were subsequently entered
into the final model for multivariable logistic regression
were: sex, SAPS II, driving pressure, FiO2, pH (mean
values from the first week after onset of ARDS), lowest
PaO2/FiO2, use of vasoactive drugs on 2 consecutive
days, metabolic acidosis, hepatic failure, renal failure,
and university/non-university hospital. (Building of the
multivariable model for patients without ARDS is
described in Additional file 1).
Finally, factors independently associated with hospital
mortality were determined using a stepwise backward
elimination procedure with a threshold of p < 0.05
according to Wald statistics. The goodness-of-fit of the
final models was assessed using the Hosmer–Lemeshow
test, and the discrimination ability was analyzed with
reference to the receiver-operator characteristic (ROC),
and its area under the curve (AUC) was calculated for
the two final models for patients with and without
ARDS.
Control for confounding to verify differences in mortality
risk in ARDS patients
Additional to and separate from the analyses of inde-
pendent risk factors, a potential difference in mortality
between ARDS patients in university and non-university
hospitals was confirmed by an additional confirmatory
analysis. This independent examination controlled for
potential predefined confounding factors present at the
onset of ARDS (e.g., demographics, comorbidity, severity
of lung injury) by means of multivariable logistic regres-
sion without further variable selection, thereby minimiz-
ing selection bias due to potential structural differences
between the two groups as well as avoiding overadjust-
ment for events occurring later during ventilation when
searching for causality.
Predefined potential confounders were derived from
the literature [6, 22, 23] and the authors’ own analysis
when factors were associated with the occurrence of
ARDS (as presented in Table 1). Selection of those po-
tential confounders eligible for statistical control was
clearly defined a priori by means of clinical assessment,
and not by statistical testing. The relevance of the differ-
ences between groups was only neglected when fulfilling
the following predefined conditions: age < 2 years, SAPS
II < 3 points, lung compliance < 3 cmH2O, PaO2/FiO2 <
10 mmHg, or differences < 2% for categorical variables.
Nevertheless, we included factors when the differences
were low but the standard deviations or interquartile
ranges differed considerably.
Based on these criteria, differences between the groups
in, for example, gender, PaO2/FiO2 at onset of ARDS,
and prevalence of renal failure or respiratory acidosis at
onset of ARDS were considered too small to distort the
relationship with mortality and were not controlled for
in the multivariable regression. In contrast, age, body
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mass index, SAPS II, main problem (medical/surgical),
origin of ARDS (pulmonary/extrapulmonary), day of on-
set of ARDS, dynamic compliance at onset of ARDS,
reasons for initiation of mechanical ventilation (postop-
erative ARF, ARF after aspiration, ARF after multiple
trauma), and comorbidities or complications present
until onset of ARDS (sepsis, pneumonia, cardiovascular
failure, coagulation failure, liver failure, metabolic acid-
osis) were selected for statistical control of confounding.
To control for confounding, we performed a one-step
multivariable logistic regression with hospital mortality
as the outcome variable, and with the academic status of
the hospital (university/non-university) and the potential
confounders as covariates. The odds ratio (OR) was cal-
culated as an effect measure for the mortality risk of
ARDS patients in non-university hospitals compared
with university hospitals. We added a sensitivity analysis
to study the robustness of this multivariable model,
varying the potential confounders by excluding factors
or combinations of factors with missing values.
Results
During May 2004, 7540 patients were admitted to the
95 participating ICUs from 80 hospitals in 64 German
cities. Of these, 1028 were ventilated for ≥ 12 h
(13.6%; 95% CI 12.9–14.4%): 914 patients were venti-
lated invasively and 114 non-invasively (of whom 56%
were intubated). The hospital mortality rate of these
1028 ventilated patients was 30.1% (95% CI 27–33%)
(Additional file 1: Table S1).
Table 1 Demographic and clinical characteristics at onset of ARDS in university and non-university hospitals
University hospital Non-university hospital
(n = 87) (n = 111) p value
Age (years) 59.0 (16.2); 63 (47–72) 62.8 (15.9); 65 (52–74) 0.10
Sex, male/female 62 (71.3)/25 (28.7) 80 (72.1)/31 (27.9) 0.9
BMI (kg/m2) 26.0 (4.9); 25.7 (23.2–27.7) 26.9 (6.2); 26.0 (23.1–29.4) 0.34
BMI categories
< 18.5/<25.5/<30.0/≥30.0 kg/m2 3 (4.5)/28 (41.8)/28 (41.8)/8 (11.9) 5 (4.7)/39 (36.8)/41 (38.7)/21(19.8) 0.6
SAPS II at ICU admission 45.2 (17.2); 42 (32–58) 48.7 (20.4); 48 (37–62) 0.21
Main problem, medical/surgical 48 (55.2)/39 (44.8) 69 (62.2)/42 (37.8) 0.32
ARDS origin, pulmonary/ extrapulmonary 65 (78.3)/18 (21.7) 79 (72.5)/30 (27.5) 0.36
Late onset of ARDSa 35 (40.2) 28 (25.2) 0.02
Onset of ARDS: day after initiation of mechanical ventilation 1 (0-5) 0 (0-2) 0.02
PaO2/FiO2 (mmHg) 157 (124-186) 149 (114-179) 0.29
Dynamic complianceb (ml/mbar; ml/mbar/kg PBW) 39 (29–55); 0.58 (0.44–0.79) 33 (24–43); 0.52 (0.39–0.67) 0.006; 0.04
Reason for initiation of mechanical ventilation (only presented when different between groups)c
Postoperative acute respiratory failure 19 (21.8) 12 (10.8) 0.03
Acute respiratory failure after aspiration 2 (2.3) 12 (10.8) 0.02
Complications until the onset of ARDS
Sepsisc 41 (47.1) 38 (34.2) 0.07
Pneumoniac 43 (49.4) 44 (39.6) 0.17
Cardiovascular failure 63 (72.4) 71 (64.0) 0.21
Renal failure 26 (29.9) 32 (28.8) 0.87
Coagulopathy 23 (26.4) 8 (7.2) <0.001
Liver failure 11 (12.6) 2 (1.8) 0.002
Metabolic acidosis 8 (9.2) 13 (11.7) 0.57
Respiratory acidosis 18 (20.7) 23 (20.7) 1.0
Barotrauma 14 (16.1) 13 (11.7) 0.37
Data presented as mean (standard deviation); median (interquartile range) or n (%)
ARDS acute respiratory distress syndrome, BMI body mass index, SAPS II Severe Acute Physiology Score II, ICU intensive care unit, PaO2/FiO2 arterial-to-inspired
oxygen ratio, PBW predicted body weight, PEEP positive end-expiratory pressure
aDefined as ARDS developing ≥48 h after the onset of mechanical ventilation
bCompliance = tidal volume / (plateau pressure – PEEP)
cAll cases as reason for initiation of mechanical ventilation or developing as complication during mechanical ventilation until the onset of ARDS. The other reasons
for the initiation of mechanical ventilation did not differ between ARDS patients in university and non-university hospitals (e.g., multiple trauma, eight vs five
patients (9.2 vs 4.5%), p = 0.19). Further details for these other reasons for the entire group of patients with ARDS are presented in Additional file 1: Table S1
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Of all ventilated patients, 19.3% (2.6% of all ICU
admissions) developed ARDS (n = 198). Patients with
ARDS developed more complications and their hospital
mortality (49.5%) was double that of patients without
ARDS (Fig. 1, Additional file 1: Tables S1 and S2). For
ARDS patients, hospital mortality was 18.2% higher in
non-university hospitals than in university hospitals;
moreover, even ventilated patients without ARDS had
higher mortality (i.e. 9.6%) in non-university hospitals
(Figs. 1 and 2).
Demographic characteristics, illness severity, and
severity of lung injury in ARDS patients were similar in
university and non-university hospitals, whereas late
ARDS and complications until onset of ARDS occurred
more frequently in the university hospitals (Table 1).
Independent from the baseline characteristics and from
Fig. 2 Probability of survival of mechanically ventilated patients after the development of ARDS, in university and non-university hospitals (after
Kaplan–Meier). ARDS acute respiratory distress syndrome, no. number
Fig. 1 Mortality of mechanically ventilated patients during their stay in the intensive care unit (ICU) and hospital, in university and non-university
hospitals. ARDS acute respiratory distress syndrome
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complications occurring later during ventilation, treat-
ment in a non-university hospital was an important in-
dependent risk factor for increased hospital mortality in
patients with ARDS (Table 2), but not in patients with-
out ARDS (Additional file 1: Table S3). Although each
hospital was characterized in detail by the setting of care
variables, these factors did not contribute to the
increased mortality risk. This increased risk in non-
university hospitals was confirmed by an additional
independent analysis, in which patient groups were com-
pared between hospitals, and potential confounding
factors at onset of ARDS were selected clinically and
statistically controlled for. This one-step multivariable
analysis showed similar and significant results, even
when one or various combinations of factors controlled
for were excluded in the sensitivity analyses (Table 3).
Of all factors related to individual patient manage-
ment, only the driving pressure and FiO2 were identified
as independent risk factors in ARDS patients, with a sig-
nificantly increasing mortality risk of 10% for every 1
cmH2O increment of driving pressure and 62% for every
0.1 increment of FiO2 (Table 2). Most of the ventilatory
and gas exchange parameters were similar between the
hospitals. However, during the first day after ARDS
Table 2 Univariable and multivariable analysis of factors associated with hospital mortality in ventilated patients with ARDS
Variable Univariable analysisa Multivariable analysisb
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Factors related to patients’ baseline factors
Sex 0.068
Male 1.82 (0.96–3.46)
Female 1
SAPS II at ICU admission 0.005
≤40 1
40–59 2.09 (1.03–4.22)
≥60 3.69 (1.64–8.29)
Factors related to individual patient management
FiO2 (0.1 increments) 1.79 (1.35–2.38) <0.001 1.62 (1.17–2.24) 0.004
Driving pressurec (1 cmH2O increments) 1.17 (1.08–1.26) <0.001 1.10 (1.02–1.20) 0.016
Use of vasoactive drugs (2 consecutive days) 2.01 (1.00–4.02) 0.049
Factors developing during mechanical ventilation
Liver failure 7.85 (2.24–27.55) 0.001 6.93 (1.68–28.59) 0.007
Renal failure 4.15 (2.25–7.64) <0.001 3.46 (1.59–7.55) 0.002
Metabolic acidosis 3.29 (1.48–7.29) 0.003 2.94 (1.03–8.27) 0.043
pHa 0.001
Acidosis (<7.35) 4.09 (1.90–8.77)
7.35–7.45 1
Alkalosis (>7.45) 1.17 (0.55–2.47)
Lowest PaO2/FiO2 (mmHg) 0.009
≤100 3.08 (1.38–6.85)
100–150 2.53 (1.26–5.10)
>150 1
Factors related to the setting of care
Non-university hospital 2.10 (1.17–3.75) 0.013 2.89 (1.31–6.38) 0.008
University hospital 1 1
ARDS acute respiratory distress syndrome, CI confidence interval, SAPS II Severe Acute Physiology Score II, ICU intensive care unit, FiO2 fraction of inspired oxygen,
PaO2 partial pressure of arterial oxygen tension, PEEP positive end-expiratory pressure
aOnly those variables are shown that qualified with p < 0.1 in the four prior multivariate analyses within the four variable categories for the overall final
multivariable model (as described in Methods and in Additional file 1, the other variables in each category including tidal volume, PEEP, hospital size, ICU size and
case volume of ventilated patients per ICU were eliminated in the multivariate analysis within each category by the presented parameters and did not qualify for
the final model)
bOnly those variables are shown that remained significant in the final multivariable model for n = 169 with stepwise backward elimination using a threshold of
p = 0.05 according to Wald statistics. Goodness of fit: Hosmer–Lemeshow test, p = 0.398; area under the receiver-operator curve, 0.84 (95% CI 0.78–0.90), p < 0.001
cDriving pressure = plateau pressure – PEEP
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onset, and also during therapeutic ventilation in univer-
sity hospitals, ARDS patients were ventilated with higher
PEEP and lower driving pressure whereas there was only
a trend for a lower FiO2 (Figs. 3 and 4, Table 4). Organ
failure was also independently associated with mortality
(Table 2); however, the incidence of organ failure and
complications after onset of ARDS was considerably
higher in the university hospitals (Table 5). Prone posi-
tioning, neuromuscular blocking, and volume-controlled
ventilation were rarely used, whereas pressure-controlled
ventilatory modes (mainly biphasic positive airway pres-
sure (BIPAP)) and pressure support ventilation were ap-
plied for ≥75% of the ventilation days (Fig. 5, Table 4).
ARDS patients underwent tracheostomy twice as fre-
quently and more often percutaneously in university
hospitals, whereas there were no differences in other
weaning characteristics (Table 6). In university hospitals,
ventilation and length of stay in the ICU of ARDS pa-
tients lasted about twice as long (Table 6), and fewer pa-
tients per ICU bed but more than twice as many
ventilated patients per ICU were treated (Table 7).
Discussion
Hospital mortality of ARDS patients in non-university
hospitals was considerably higher than in university hos-
pitals; moreover, treatment in non-university hospitals
was an important risk factor in ARDS patients, increas-
ing the mortality risk to an extent similar to that of renal
failure, independent of illness severity, the occurrence of
organ failure, or other variables. Although the study de-
sign was observational and, therefore, the two groups
were not compiled by randomization, the remarkable
difference in mortality was not due to differences be-
tween the groups; that is, in both groups patients were
very similar with respect to important demographic and
clinical criteria (e.g., age, SAPS II, underlying disease,
and PaO2/FiO2 at onset of ARDS). Even though the
groups could not be equal based on the study design,
when considering the predefined potential confounders
at the onset of ARDS, the difference in mortality risk be-
tween university and non-university hospitals was still
significant and substantial. Our study seems to be the
first to provide statistically robust evidence that ARDS
treatment in non-university hospitals is associated with
higher mortality compared with university hospitals.
Decades ago, Lachmann [26, 27] suggested using ven-
tilation modes that allow the lowest possible driving
pressure in an open ARDS lung in order to prevent lung
damage due to high shear forces between open and
closed lung units. Driving pressure and FiO2, but neither
PEEP nor other ventilatory variables, were independently
associated with increased mortality in ARDS patients.
Increasing driving pressure and FiO2 reflect more severe
stages of ARDS but also further aggravate lung injury
[26]. Although increasing PEEP also reflects more severe
stages of ARDS, low values increase mortality (as op-
posed to driving pressure and FiO2) by further aggravat-
ing lung injury [15, 23, 26, 28]. This nonlinear
relationship between mortality and PEEP in ARDS may
explain that neither increasing nor decreasing PEEP was
associated with increasing mortality in our multivariable
analysis. However, adequate PEEP prevents atelectasis,
Table 3 Control for confounding and sensitivity analyses with a further multivariable model including only potential confounders at
ARDS onset
Odds ratio for hospital mortality of ARDS patients in non-university
hospitals vs university hospitals
na Odds ratio multivariable p value
Multivariable analysis with all potential confounders 128 2.8 (1.1–7.1) 0.035
Excluding SAPS II 137 2.7 (1.1–6.6) 0.032
Excluding BMI 142 3.5 (1.5–8.4) 0.004
Excluding compliance 151 2.4 (1.1–5.5) 0.037
Excluding SAPS II, BMI 151 3.4 (1.5–7.7) 0.005
Excluding compliance, SAPS II 164 2.4 (1.1–5.4) 0.028
Excluding compliance, BMI 174 3.5 (1.7–7.6) 0.001
Excluding compliance, SAPS II, BMI 189 3.3 (1.6–6.7) 0.001
The consistency of results of these sensitivity analyses indicates that this multivariable model including only potential confounders was robust with respect to
alterations of included variables or to the corresponding changes of the study group
To control for confounding only potential confounders were considered in this further multivariate model, including factors that differ between ARDS patients in
university and non-university hospitals at onset of ARDS and also including those factors that did not differ significantly but only numerically between groups
(Table 1): age, BMI, SAPS II, main problem (medical/surgical), ARDS origin (pulmonary/extrapulmonary), day of ARDS onset, dynamic compliance at ARDS onset,
reason for initiation of mechanical ventilation, (postoperative acute respiratory failure (ARF), ARF after aspiration, ARF after multiple trauma), and comorbidities or
complications present until onset of ARDS (sepsis, pneumonia, cardiovascular failure, coagulation failure, liver failure, metabolic acidosis)
ARDS acute respiratory distress syndrome, SAPS II Severe Acute Physiology Score II, BMI body mass index
aNumber of ARDS patients included in the respective multivariable analysis after excluding factors or various combinations of factors with missing values (SAPS II
5% missing values, BMI 7%, compliance 12%) (all ARDS patients n = 198, eight patients without outcome variable, one patient without age)
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alveolar flooding, and collapse and is therefore a precon-
dition for both lower driving pressures and FiO2 by
maintaining lung volume and area for gas exchange in
ARDS [5, 23]. Then again, low PEEP results in higher
driving pressures (due to less aerated lung volume), but
also in higher FiO2 to maintain oxygenation with a
smaller area for gas exchange [15–22, 24, 26]. Accord-
ingly, as in the present analysis, in the multivariable
analysis performed by Ferguson et al. [23] of ARDS
patients in the First VENTILA study, increases in FiO2
(and not decreases in PaO2/FiO2), with very similar ORs,
were independently associated with mortality.
Fig. 3 Change over time in ventilatory parameters during the first week after onset of ARDS. a Driving pressure (= plateau pressure – PEEP), b plateau
pressure, c PEEP, d compliance (= tidal volume / (plateau pressure – PEEP)), e respiratory rate, f tidal volume/kg predicted body weight. Error bars show
95% confidence intervals. *Differences between university and non-university hospitals during the day after onset of ARDS (mean ± SD): driving pressure,
14.9 ± 5.6 vs 17.3 ± 5.5 cmH2O, p= 0.007; PEEP, 10.2 ± 5.1 vs 8.0 ± 4.1 cmH2O, p= 0.002; compliance, 47.9 ± 28.0 vs 36.8 ± 19.9 ml/cmH2O, p= 0.006. PEEP
also differed between university and non-university hospitals during the second day after the onset of ARDS: 10.3 ± 4.9 vs 8.4 ± 4.0 cmH2O, p= 0.004.
PEEP positive end-expiratory pressure
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Driving pressure was not included in this analysis by
Ferguson et al. [23], or in that of the KCLIP study [22] or
in other multivariable analyses performed in ARDS pa-
tients [9, 12, 14], with the exception of the recent analysis
by Amato et al. [24]. These latter authors analyzed nine
randomized ARDS trials (including 17-year-old data) and,
as in the present analysis, also found that both driving
pressure and FiO2 were significantly associated with sur-
vival [24]. Our analysis is the first to confirm their findings
and, surprisingly, our results are very similar despite the
use of different methods (e.g., Amato et al. used the mean
driving pressure of the first 24 h after randomization and
we used the mean value of the first week after onset of
ARDS in an observational study). In the present study, the
OR that indicates increased mortality risk with higher
driving pressure for ARDS patients in university hospitals
corresponds to a very similar relative risk when compared
with Amato et al. [24] (Additional file 1: Figure S1).
Fig. 4 Change over time in gas exchange parameters and pH after onset of ARDS. a Partial pressure of arterial oxygen tension (PaO2), b fraction
of inspired oxygen (FiO2), c arterial-to-inspired-oxygen (PaO2/FiO2), d partial pressure of arterial carbon dioxide tension (PaCO2), e pH. Error bars
show 95% confidence intervals
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Table 4 Ventilatory characteristics and adjunctive therapies during the first week after ARDS onset in university and non-university
hospitals
University hospital (n = 87; 592
days of mechanical ventilation)
Non-university hospital (n = 111;
599 days of mechanical ventilation)
p value
Ventilatory parameters averaged over the first week after ARDS onset, mean (SD); median (IQR)
Driving pressurea (cmH2O) 15.7 (5.1); 15 (13–19) 16.3 (4.7); 16 (13–19) 0.40
Driving pressure when FiO2 > 0.4 and PEEP ≥ 5 (cmH2O)
b 15.1 (4.4); 16 (12–19) 17.0 (5.0); 18 (14–20) 0.02
PEEP (cmH2O) 10.1 (4.2); 10 (7–13) 8.4 (3.9); 8 (6–11) 0.005
PEEP when FiO2 > 0.4 and PEEP ≥ 5 (cmH2O)
b 11.7 (4.7); 10 (8–15) 9.7 (3.7); 9 (7–12) 0.005
PEEP categories, n (%)
≤5 cmH2O 11 (12.6) 24 (21.8) 0.05
≤10 cmH2O 41 (47.1) 58 (52.7)
≥11 cmH2O 35 (40.2) 28 (25.5)
Tidal volume (ml/kg PBW) 8.9 (2.0); 8.6 (7.6–10.0) 8.9 (2.4); 8.7 (7.6–10.0) 0.99
Plateau pressure (cmH2O) 26.4 (5.8); 27 (23–31) 25.3 (5.4); 25 (22–28) 0.18
Plateau pressure categories, n (%)
≤30 cmH2O 54 (70.1) 89 (86.4) 0.007
>30 cmH2O 23 (29.9) 14 (13.6)
Compliancec (ml/mbar; ml/mbar/kg PBW) 42 (32–54); 0.62 (0.49–0.80) 38 (29–48); 0.59 (0.45–0.73) 0.06;
0.23
Respiratory frequency (breaths/min) 20 (16–22) 18 (13–22) 0.17
FiO2 0.44 (0.40–0.54) 0.48 (0.41–0.57) 0.07
PaO2 (mmHg) 91 (84–105) 92 (78–107) 0.64
PaO2/FiO2 (mmHg) 208 (169–250) 194 (155–248) 0.19
PaCO2 (mmHg) 42 (38–47) 42 (37–48) 0.91
pHa 7.41 (7.36–7.45) 7.42 (7.36–7.46) 0.59
Days with ventilatory mode during the first week after ARDS onset, n (% of all days of mechanical ventilation) <0.001
Biphasic intermittent positive airway pressure 281 (47.5) 271 (45.2) 0.44
Pressure controlled ventilation 69 (11.7) 111 (18.5) 0.001
Pressure support ventilation 105 (17.7) 75 (12.5) 0.01
SIMV + pressure support ventilation 31 (5.2) 41 (6.8) 0.24
SIMV 24 (4.1) 10 (1.7) 0.01
Volume-controlled ventilation (assist/control) 28 (4.7) 15 (2.5) 0.04
Non-invasive ventilation 31 (5.2) 38 (6.3) 0.41
Other 9 (1.5) 7 (1.2) 0.60
Not specified 14 (2.4) 31 (5.2) 0.01
Days applying adjunctive therapies, n (% of all days of mechanical ventilation); median (IQR)
Prone positioning or rotation bed, all days 44 (7.4) 22 (3.7) 0.005
Sedatives all days, duration/patient (days) 439 (74.2); 12 (7–21) 411 (56.8); 5 (2–10) 0.03;
<0.001
Neuromuscular blocking agents, all days 11 (1.9) 7 (1.2) 0.33
ARDS acute respiratory distress syndrome, FiO2 fraction of inspired oxygen, PaO2 partial pressure of arterial oxygen tension, PaO2/FiO2 arterial-to-inspired oxygen
ratio, PEEP positive end-expiratory pressure, PBW predicted body weight, SIMV Synchronized intermittent mandatory ventilation, SD standard deviation, IQR
interquartile range
aDriving pressure = plateau pressure – PEEP
bAll other ventilatory parameters during therapeutic ventilation did not differ between groups in this sensitivity analysis, including only those ventilation days –
during the first week after ARDS onset with FiO2 > 0.4 and PEEP ≥ 5 cmH2O – that represented minimum values as criteria for the start of weaning in the low tidal
volume trial of the ARDS Network [12] (261 of 592 days (44.1%) in university hospitals and 299 of 599 days (49.9%) in non-university hospitals)
cCompliance = tidal volume / (plateau pressure – PEEP)
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Although any comparisons between studies across na-
tional borders must be interpreted with considerable
caution, the increased mortality found in German non-
university hospitals was not excessively high but was
very similar to other observational studies (despite
higher age and SAPS II) [9, 10]; in contrast, despite
SAPS II being 13 points higher, mortality of ARDS in
non-university hospitals was 5.7% lower compared with
the other 22 countries of the Second VENTILA study
[7]. Therefore, in the present study, the considerable
difference in mortality between the university and non-
university hospitals cannot be attributed to exceedingly
high mortality in the non-university hospitals but rather
to the relatively low mortality rate of 39.3% in the
university hospitals (being 8.5% lower than that in the
ALIEN study [11]).
In ventilated patients, organ failure is associated with in-
creased mortality [6, 12, 14] and this was also the case in
Fig. 5 Ventilatory modes used during the first week after the onset of ARDS in patients in university and non-university hospitals. Pressure support
ventilation was used both more often and earlier in university hospitals than in non-university hospitals (see Table 6 for p values). A/C (VC-CMV)
denotes assist/control (volume-controlled continuous mechanical ventilation), PCV (PC-CMV) pressure-controlled ventilation (pressure-controlled
continuous mechanical ventilation), BIPAP/APRV biphasic positive airway pressure/airway pressure release ventilation, PSV pressure-support ventilation,
SIMV synchronized intermittent mandatory ventilation, NIV non-invasive ventilation
Table 5 Incidence of complications developing after ARDS onset in university and non-university hospitals
Incidence Incidence rate
University hospital
(n = 87)
Non-university hospital
(n = 111)
University hospital (n = 87) Non-university hospital (n = 111)
na (%) na (%) p value Rate/1000 daysb (analyzed daysc) Rate/1000 daysb (analyzed daysc)
Sepsis 8/46 (17.4) 3/73 (4.1) 0.02 12 (671) 5 (653)
Pneumonia 17/44 (38.6) 13/67 (19.4) 0.03 30 (570) 21 (609)
Cardiovascular failure 11/24 (45.8) 12/40 (30) 0.20 38 (289) 28 (423)
Liver failure 7/76 (9.2) 3/109 (2.8) 0.09 6 (1139) 3 (972)
Renal failure 15/61 (24.6) 11/79 (13.9) 0.11 16 (942) 15 (755)
Coagulopathy 13/64 (20.3) 8/103 (7.8) 0.02 13 (966) 9 (916)
Metabolic acidosis 7/79 (8.9) 8/98 (8.2) 0.87 6 (1159) 9 (911)
Respiratory acidosis 16/69 (23.2) 9/88 (10.2) 0.03 17 (995) 11 (795)
Barotrauma 2/23 (2.7) 0/98 (0) 0.18 2 (1099) 0 (849)
ARDS acute respiratory distress syndrome
aNumber of patients who developed this complication after the first day of ARDS onset as a proportion of those patients without this complication until
ARDS onset
bIncidence rate of the complication after the first day of ARDS onset per 1000 days of mechanical ventilation in those patients without this complication until
ARDS onset
cRemaining days for analysis of a total of 1249 days of mechanical ventilation after ARDS onset in university hospitals and 988 days in non-university hospitals (ob-
servation only during mechanical ventilation and up to 28 days after initiation of mechanical ventilation)
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the present analysis. Surprisingly, the outcome of ARDS
patients in university hospitals was better even though
organ failure and complications occurred considerably
more often, even when taking into account different ob-
servation periods by comparing incidence rates rather
than proportions. Finally, because the difference in mor-
tality was not related to organ failure, complications,
illness severity, or patient characteristics, the unequal
outcome of ARDS is most likely related to differences in
treatment practices. Ventilatory modes and adjunctive
therapies did not differ sufficiently to really contribute to
the unequal mortality, and there was only a trend for use
of a higher FiO2 in non-university hospitals. Tidal volumes
and plateau pressures also did not differ between the
groups, but PEEP was higher and driving pressure was
lower in university hospitals during therapeutic ventila-
tion. In the German university hospitals, driving pressures
of about 15 cmH2O were similar to those in the ALIEN
study [11] and in the meta-analysis performed by Briel et
al. [28], despite tidal volumes being higher to the extent of
2 and 2.6 ml/kg predicted body weight, respectively. How-
ever, in contrast to the present analysis, higher PEEP did
not lead to lower driving pressures in the meta-analysis by
Briel et al., and the authors found a difference in mortality
rate of only 5% [28]. In our study, because higher driving
pressures and FiO2 were independently associated with in-
creased mortality, and because higher PEEP is the precon-
dition to reduce both variables, the differences in
ventilatory therapy between university and non-university
hospitals may partially explain the unequal outcome of
ARDS patients.
In the university hospitals, the duration of ventilation
and ICU stay was similar to that in the ALIEN study
[11] and twice as high as that in non-university hospi-
tals. The higher rate of complications in university
hospitals may be a result of, but also a contributory
cause of, longer ventilation. Non-invasive ventilation
after extubation, reintubation rates, timing of tracheos-
tomy, and other weaning characteristics did not differ
between groups. However, in the university hospitals,
tracheostomy was performed twice as frequently and
more often percutaneously, and this is reported to be
associated with a lower risk of wound infection than a
surgical tracheostomy [29]. The difference in ICU
Table 6 Characteristics of weaning and duration of mechanical ventilation, ICU and hospital stay in patients with ARDS
University hospital
(n = 87)
Non-university hospital
(n = 111)
p value
Tracheostomy 0.16
Tracheostomy after ARDS onset/nontracheostomized patients until ARDS onset 33/76 (43.4) 20/102 (19.6) 0.001
Tracheostomy, percutaneous /surgical/not specified 29 (87.9)/3 (9.1)/1 (3.0) 11 (55.0)/8 (40.0)/1 (5.0) 0.01
Days to tracheostomy after ARDS onset 10 (4–13) 4 (2–11) 0.10
Main weaning method 0.16
Daily spontaneous weaning trial 12 (19.7) 25 (34.7)
Gradual reduction of ventilatory support 45 (73.8) 43 (59.7)
Not specified 4 (6.6) 4 (5.6)
Extubation
Extubation 42/86 (48.8) 63/107 (58.9) 0.16
Reintubation within 48 h 17/42 (40.5) 16/53 (25.4) 0.10
Non-invasive ventilation after extubation; reintubation thereafter 23/42 (54.8); 10 (43.5) 27/63 (42.9); 12 (44.4) 0.23; 0.95
Duration of mechanical ventilation (days) 16 (9–29) 8 (3–16) <0.001
After ARDS onset 13 (6–23) 6 (3–14) <0.001
Survivors 14 (9–25) 7 (3–14) <0.001
Length of ICU stay (days) 19 (12–34) 10 (5–23) <0.001
After initiation of mechanical ventilation 19 (11–34) 10 (5–24) <0.001
After ARDS onset 15 (9–31) 8 (4–18) <0.001
Survivors 19 (13–35) 13 (5–24) 0.003
Length of hospital stay (days) 31 (17–46) 21 (9–41) 0.007
After initiation of mechanical ventilation 26 (14–42) 15 (6–34) 0.002
After ARDS onset 23 (11–37) 14 (4–28) 0.005
Survivors 32 (19–53) 24 (14–41) 0.077
Data presented as n (%); median (interquartile range)
ARDS acute respiratory distress syndrome, ICU intensive care unit
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mortality between university and non-university hospi-
tals was not significant, and only half that of the differ-
ence in overall hospital mortality. Although the reason
for this considerably increased difference in mortality
after ICU discharge remains unknown, a possible
explanation could be that in non-university hospitals the
ventilatory therapy was too short and discharge from the
ICU too early for some of the patients. This may lead to
reconsideration about the sufficient duration of ventila-
tion and ICU therapy when patients develop ARDS,
rather than focusing on surrogate outcomes such as
ventilator-free days [17, 18].
In the ICUs of the university hospitals more than twice
as many ventilated patients per ICU were treated com-
pared with non-university hospitals; however, the
percentage of ventilated patients was still considerably less
compared with other countries [6, 7]. Kahn et al. [30]
demonstrated that the high case volume of ventilated pa-
tients is independently associated with better survival in
nonsurgical patients. This annualized hospital volume
cannot be directly compared with our case volume of ven-
tilated nonsurgical and surgical patients per ICU, because
most of our hospitals had various ICUs that did not par-
ticipate in the present study; therefore, our ICU volume
does not fully represent hospital volume. In patients with-
out ARDS, this ICU volume was an independent risk fac-
tor with a significantly decreasing mortality risk of 18%
for every increment of 10 ventilated patients per month.
In patients with ARDS, the ICU volume was not inde-
pendently associated with mortality, which does not prove
a missing association between case volume and mortality.
On the other hand, some ICUs with a very low case
volume of ventilated patients were included and this is
likely to be an important factor.
Apart from mechanical ventilation, many other aspects of
treatment are important for the outcome of these severely
ill patients, and these items may also differ between hospi-
tals. This includes, in particular, the effective and perhaps
more time-consuming multidisciplinary treatment of both
underlying diseases and complications, the presence of
trained physicians and intensivists, an adequate nurse-to-
patient ratio and staff workload, the implementation of
protocols, as well as other factors that were not assessed in
the Second VENTILA study [13, 31–33].
Limitations
The idea for this present analysis came rather late and
took a considerable amount of time, and the data are
now more than 10 years old. However, due to an
increasing lack of physicians, many non-university hos-
pitals included in the present analysis did not participate
in the more recent VENTILA studies [8]; therefore,
these data from 2004 are still the best data available.
Moreover, this is the last study undertaken before
Table 7 Setting of care in university and non-university hospitals
University hospital Non-university hospital p value
Number of hospitals 18 (22.5) 62 (77.5)
Number of participating ICUs 33 (34.7) 62 (65.3)
Beds per hospital 1275 (1189–1444) 367 (280–526) <0.001
Beds per ICU 13 (10–16) 9 (7–12) 0.001
ICU size category
< 5/<8/ <14/ ≥14 beds per ICU 4 (12.1)/3 (9.1)/9 (27.3)/17 (51.5) 18 (29)/21 (33.9)/18 (29)/5 (8.1) <0.001
Total number of all ICU beds 465 (43.2) 612 (56.8)
ICU specialization <0.001
Surgical/medical 6 (18.2) 41 (66.1)
Medical 8 (24.2) 6 (9.7)
Surgical 16 (48.5) 15 (24.2)
Neurological 3 (9.1) 0
Number of all ICU patients 2994 (39.7) 4546 (60.3)
Patients per ICU 74 (51–106) 74 (49–98) 0.47
Patients per ICU bed 5.8 (4.4–8.0) 7.7 (5.2–9.6) 0.04
Number of ventilated patients 558 (54.3) 470 (45.7)
Ventilated patients per ICU 14 (8–23) 6 (4–10) <0.001
Ventilated patients per ICU bed 1.0 (0.7–1.5) 0.7 (0.5–1.0) 0.002
% ventilated patients in all ICUs 19 (12–27) 10 (6–15) <0.001
Data presented as n (%) or median (interquartile range)
ICU intensive care unit
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extracorporeal lung assist devices were widely intro-
duced in Germany, with a possible impact on outcome
[34]. However, it is unknown whether our findings can
be extrapolated to other countries and to what extent
they represent the current state of therapy in Germany.
In addition, the enormous difference in the duration of
ventilation which goes in the opposite direction to mor-
tality, and the extremely high number of reintubations
in both university and non-university hospitals, may also
indicate that considerable caution is required when
transferring our data to other settings. Tidal volumes
were high and did not differ between the groups but
non-university hospitals used less lung protective venti-
lation; this might suggest slower implementation of lung
protective strategies at that time compared with univer-
sity hospitals, whereas this might not be true today.
Nevertheless, the Large Observational Study to Under-
stand the Global Impact of Severe Acute Respiratory
Failure (LUNG SAFE) showed that, in 2014, there were
still major problems with the diagnosis of ARDS and the
implementation of lung protective ventilation [35]. Po-
tential bias due to selection is a further limitation of our
analysis as we included only those hospitals that volun-
teered to participate. Nevertheless, the 80 participating
hospitals were located throughout Germany and non-
university hospitals were not underrepresented as
compared with other observational studies [9–13] but,
conversely, constituted ≥75% of the participating hospi-
tals thereby including ≥50% of the ARDS patients.
Conclusions
The care setting had an important impact on ARDS outcome,
as the mortality risk in non-university hospitals was some-
times even tripled compared with that in university hospitals.
Differences in ventilatory care included: a 2 cmH2O higher
PEEP combined with a 2 cmH2O lower driving pressure; ven-
tilation that lasted twice as long in university hospitals; and
the case volume of ventilated patients per ICU was more
than doubled in university hospitals compared with that in
non-university hospitals. The combination of lower driving
pressure with higher PEEP, and other approaches to reduce
both driving pressure and FiO2, represent prognostically rele-
vant treatment goals in ARDS that are exportable to non-
university hospitals. In addition, our results may also indicate
the need to further examine those practices common in uni-
versity hospitals that favor better outcome in ARDS, as they
may be transferable to non-university hospitals.
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study: International Study of Mechanical Ventilation
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